Articles with public access mandates - Shivani GargLearn more
Not available anywhere: 1
A modular approach for high-flux lactic acid production from methane in an industrial medium using engineered Methylomicrobium buryatense 5GB1
S Garg, JM Clomburg, R Gonzalez
Journal of Industrial Microbiology and Biotechnology 45 (6), 379-391, 2018
Mandates: US Department of Energy
Available somewhere: 15
In vitro prototyping and rapid optimization of biosynthetic enzymes for cell design
AS Karim, QM Dudley, A Juminaga, Y Yuan, SA Crowe, JT Heggestad, ...
Nature Chemical Biology 16 (8), 912-919, 2020
Mandates: US Department of Energy
Advances in systems metabolic engineering of autotrophic carbon oxide-fixing biocatalysts towards a circular economy
M Pavan, K Reinmets, S Garg, AP Mueller, E Marcellin, M Köpke, ...
Metabolic Engineering 71, 117-141, 2022
Mandates: US Department of Energy, Australian Research Council, European Commission
Bioconversion of methane to C-4 carboxylic acids using carbon flux through acetyl-CoA in engineered Methylomicrobium buryatense 5GB1C
S Garg, H Wu, JM Clomburg, GN Bennett
Metabolic engineering 48, 175-183, 2018
Mandates: US Department of Energy
Cell-free prototyping enables implementation of optimized reverse β-oxidation pathways in heterotrophic and autotrophic bacteria
B Vögeli, L Schulz, S Garg, K Tarasava, JM Clomburg, SH Lee, A Gonnot, ...
Nature communications 13 (1), 3058, 2022
Mandates: US Department of Energy, Swiss National Science Foundation
Investigating lupus retention in care to inform interventions for disparities reduction: an observational cohort study
CM Bartels, A Rosenthal, X Wang, U Ahmad, I Chang, N Ezeh, S Garg, ...
Arthritis research & therapy 22, 1-9, 2020
Mandates: US National Institutes of Health
Modular cell-free expression plasmids to accelerate biological design in cells
AS Karim, F Liew, S Garg, B Vögeli, BJ Rasor, A Gonnot, M Pavan, ...
Synthetic Biology 5 (1), ysaa019, 2020
Mandates: US Department of Energy, Swiss National Science Foundation
One quarter of medicare hospitalizations in patients with systemic lupus erythematosus readmitted within thirty days
CM Bartels, A Chodara, Y Chen, X Wang, WR Powell, F Shi, ...
Seminars in arthritis and rheumatism 51 (2), 477-485, 2021
Mandates: US National Institutes of Health
High burden of premature arteriosclerosis on renal biopsy results in incident lupus nephritis
S Garg, CM Bartels, KE Hansen, W Zhong, Y Huang, MG Semanik, ...
Arthritis care & research 73 (3), 394-401, 2021
Mandates: US National Institutes of Health
X-linked genes exhibit miR6891-5p-regulated skewing in Sjögren’s syndrome
TM Shaw, W Zhang, SS McCoy, A Pagenkopf, DM Carp, S Garg, ...
Journal of Molecular Medicine 100 (9), 1253-1265, 2022
Mandates: US National Institutes of Health
Patient and healthcare team recommended medication adherence strategies for hydroxychloroquine: results of a qualitative study informing intervention development
S Garg, B Chewning, D Gazeley, S Gomez, N Kaitz, AC Weber, ...
Lupus Science & Medicine 9 (1), e000720, 2022
Mandates: US National Institutes of Health
The effect of IL-6 inhibitors on mortality among hospitalized COVID-19 patients: a multicenter Study
P Sinha, SR Jafarzadeh, SA Assoumou, CG Bielick, B Carpenter, S Garg, ...
The Journal of Infectious Diseases 223 (4), 581-588, 2021
Mandates: US National Institutes of Health
Association of renal arteriosclerosis with atherosclerotic cardiovascular disease risk in lupus nephritis
S Garg, AN Raval, KE Hansen, W Zhong, Y Huang, M Smith, SE Panzer, ...
Arthritis care & research 74 (7), 1105-1112, 2022
Mandates: US National Institutes of Health
Smoking exposure in pack-years predicts cutaneous manifestations and damage in systemic lupus erythematosus
N Ezeh, T McKown, S Garg, CM Bartels
Lupus 30 (4), 649-654, 2021
Mandates: US National Institutes of Health
Clarifying misbeliefs about hydroxychloroquine (HCQ): developing the HCQ benefits versus harm decision aid (HCQ-SAFE) per low health literacy standards
S Garg, S Ferguson, B Chewning, S Gomez, J Keevil, C Bartels
Lupus Science & Medicine 10 (2), e000935, 2023
Mandates: US National Institutes of Health
POS1126 THERAPEUTIC RANGE OF HYDROXYCHLOROQUINE BLOOD LEVELS CAN REDUCE ODDS OF HIGH LUPUS DISEASE ACTIVITY
S Garg, B Chewning, S Gomez, C Bartels
Annals of the Rheumatic Diseases 82 (Suppl 1), 890-891, 2023
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program